CONNECTIVE TISSUE DISEASES What does the death of Riquent™ hold for the future of SLE?

被引:5
作者
Merrill, Joan T. [1 ]
Buyon, Jill P. [2 ]
机构
[1] Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA
[2] NYU, Sch Med, New York, NY USA
关键词
SYSTEMIC-LUPUS-ERYTHEMATOSUS; ABETIMUS SODIUM; RENAL FLARE; LJP-394;
D O I
10.1038/nrrheum.2009.99
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In clinical trials testing new treatments for systemic lupus erythematosus (SLE), the failure of the 15-year drug development program for Riquent™ (abetimus sodium) is the latest in a string of disappointments for a disease that has seen no new drugs approved in over 50 years.
引用
收藏
页码:306 / 307
页数:2
相关论文
共 10 条
[1]   Baseline characteristics of a multiethnic lupus cohort:: PROFILE [J].
Alarcón, GS ;
McGwin, G ;
Petri, M ;
Reveille, JD ;
Ramsey-Goldman, R ;
Kimberly, RP .
LUPUS, 2002, 11 (02) :95-101
[2]   LJP 394 for the prevention of renal flare in patients with systemic lupus erythematosus -: Results from a randomized, double-blind, placebo-controlled study [J].
Alarcón-Segovia, D ;
Tumlin, JA ;
Furie, RA ;
McKay, JD ;
Cardiel, MH ;
Strand, V ;
Bagin, RG ;
Linnik, MD ;
Hepburn, B .
ARTHRITIS AND RHEUMATISM, 2003, 48 (02) :442-454
[3]   NEONATAL LUPUS SYNDROMES [J].
BUYON, JP .
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 1992, 28 (3-4) :259-263
[4]   Abetimus sodium for renal flare in systemic lupus erythematosus [J].
Cardiel, Mario H. ;
Tumlin, James A. ;
Furie, Richard A. ;
Wallace, Daniel J. ;
Joh, Tenshang ;
Linnik, Matthew D. .
ARTHRITIS AND RHEUMATISM, 2008, 58 (08) :2470-2480
[5]  
DEY E, 2009, UPDATE 2 JOLLA STOPS
[6]   Newer therapeutic approaches for systemic lupus erythematosus: Immunosuppressive agents [J].
Dooley, MA ;
Ginzler, EM .
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2006, 32 (01) :91-+
[7]  
Furie RA, 2001, J RHEUMATOL, V28, P257
[8]   Pharmacokinetics of high-dose abetimus sodium in normal subjects with specific assessment of effect on coagulation [J].
Linnik, Matthew D. ;
O'Rourke, Anne M. ;
Crowther, Mark A. .
JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 48 (08) :909-918
[9]  
López P, 2008, J RHEUMATOL, V35, P1559
[10]  
2009, STUDY LIP 394 LUPUS